Betaine in human nutrition

American Journal of Clinical Nutrition

Volumn 80, Issue 3, 2004, Pages 539-549

  Craig, Stuart A S ^a  

^a GENENCOR INTERNATIONAL INC   (United States)

Author keywords

Betaine; Heart; Homocysteine; Lipotrope; Liver; Methylation; Osmolyte

Indexed keywords

BETAINE; DNA; ENZYME; FAT; HOMOCYSTEINE; LIVER PROTEIN; METHIONINE; METHYL GROUP; PROTEIN; S ADENOSYLMETHIONINE; WATER; GASTROINTESTINAL AGENT; LIPOTROPIC AGENT; METHYLTRANSFERASE;

BODY GROWTH; BRAIN DISEASE; BRAN; CARDIOVASCULAR RISK; CELL PROTECTION; CHRONIC DISEASE; CONCENTRATION (PARAMETERS); CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIETARY INTAKE; DNA METHYLATION; DYSLIPIDEMIA; FOOD INTAKE; HEALTH STATUS; HUMAN; INVERTEBRATE; KIDNEY FUNCTION; LIPID METABOLISM; LIPID STORAGE; LIVER DISEASE; LIVER FUNCTION; LIVER METABOLISM; MARINE ENVIRONMENT; METHYLATION; MICROORGANISM; NUTRIENT; NUTRITION; PLANT; POPULATION RESEARCH; PROPHYLAXIS; PROTEIN METABOLISM; REVIEW; SALINITY; SEA FOOD; SPINACH; STEATOSIS; STRESS; TASK PERFORMANCE; TEMPERATURE; VASCULAR DISEASE; WHEAT GERM; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECT; HYPERHOMOCYSTEINEMIA; INTESTINE ABSORPTION; KIDNEY DISEASE; LIVER; METABOLISM; OSMOLARITY;

ANIMALIA; INVERTEBRATA; SPINACIA OLERACEA; TRITICUM AESTIVUM;

ANIMALS; BETAINE; CARDIOVASCULAR DISEASES; DNA METHYLATION; GASTROINTESTINAL AGENTS; HUMANS; HYPERHOMOCYSTEINEMIA; INTESTINAL ABSORPTION; KIDNEY DISEASES; LIPOTROPIC AGENTS; LIVER; LIVER DISEASES; METHIONINE; METHYLTRANSFERASES; OSMOLAR CONCENTRATION;

EID: 4544358286     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.3.539     Document Type: Review

References (271)

1. Sakamoto A, Nishimura Y, Ono H, Sakura N. Betaine and homocysteine concentrations in foods. Pediatr Int 2002;44:409-13.
2. Koc H, Mar MH, Ranasinghe A, Swenberg JA, Zeisel SH. Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/ electrospray ionization-isotope dilution mass spectrometry. Anal Chem 2002;74:4734-40.
3. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003;133:1302-7.
4. Budavari S, ed. The Merck index. 11th ed. Rahway, NJ: Merck & Co, Inc, 1989.
5. Guggenheim M. Betaine. In: Die Biogenen Amine. [The biogenic amines.] Basel, Switzerland: Karger, 1951:240-2(in German).
6. Hendler SS, Rorvik D, eds. PDR for nutritional supplements. 1st ed. Montvale, NJ: Medical Economics, 2001.
7. LeRudulier D, Strom AR, Dandelkar AM, Smith LT, Valentine RC. Molecular biology of osmoregulation. Science 1984;224:1064-8.
8. Konosu S, Hayashi T. Determination of beta-alanine betaine and glycine betaine in some marine invertebrates. Bull Jpn Soc Sci Fisheries 1975;41:743-6.
9. Konosu S, Yamaguchi K. The flavor components in fish and shellfish. In: Flick GJ, Hebard CE, Ward DR, eds. Chemistry and biochemistry of marine food products. Westport, CT: AVI Publishing Co, 1982.
10. Waggle DH, Lambert MA, Miller GD, Parrel EP, Deyoe CW. Extensive analyses of flours and millfeeds made from nine different wheat mixes. II. Amino acids, minerals, vitamins, and gross energy. Cereal Chem 1967;44:48-60.
11. Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN. Living with water stress: evolution of osmolyte systems. Science 1982;217:1214-22.
12. Betaine. Monograph. Altern Med Rev 2003;8:193-6.
13. Virtanen E. Piecing together the betaine puzzle. Feed Mix 1995;3:12-7.
14. McCue KF, Hanson AD. Salt-inducible betaine aldehyde dehydrogenase from sugar beet: cDNA cloning and expression. Plant Mol Biol 1992;18:1-11.
15. Rudolph AS, Crowe JH, Crowe LM. Effects of three stabilizing agents-proline, betaine, and trehalose-on membrane phospholipids. Arch Biochem Biophys 1986;245:134-43.
16. Murata N, Mohanty PS, Hayashi H, Papageorgiou GC. Glycinebetaine stabilizes the association of extrinsic proteins with the photosynthetic oxygen-evolving complex. FEBS Lett 1992;296:187-9.
17. Courtenay ES, Capp MW, Anderson CF, Record MT Jr. Vapor pressure osmometry studies of osmolyte-protein interactions: implications for the action of osmoprotectants in vivo and for the interpretation of "osmotic stress" experiments in vitro. Biochemistry 2000;39:4455-71.
18. Ko R, Smith LT, Smith GM. Glycine betaine confers enhanced osmotolerance and cryotolerance on Listeria monocytogenes. J Bacteriol 1994;176:426-31.
19. Brigulla M, Hoffmann T, Krisp A, Volker A, Bremer E, Volker U. Chill induction of the SigB-dependent general stress response in Bacillus subtilis and its contribution to low-temperature adaptation. J Bacteriol 2003;185:4305-14.
20. McCue KF, Hanson AD. Drought and salt tolerance: towards understanding and application. Trends Biotechnol 1990;8:358-62.
21. Fetterer RH, Augustine PC, Allen PC, Barfield RC. The effect of dietary betaine on intestinal and plasma levels of betaine in uninfected and coccidia-infected broiler chicks. Parasitol Res 2003;90:343-8.
22. Kettunen H, Tiihonen K, Peuranen S, Saarinen MT, Remus JC. Dietary betaine accumulates in the liver and intestinal tissue and stabilizes the intestinal epithelial structure in healthy and coccidia-infected broiler chicks. Comp Biochem Physiol A Mol Integr Physiol 2001;130:759-69.
23. Kidd MT, Ferket PR, Garlich JD. Nutritional and osmoregulatory functions of betaine. Worlds Poult Sci J 1997;53:125-39.
24. Virtanen E, Campbell RG. Reduction of backfat thickness through betaine supplementation of diets for fattening pigs. In: Handbuch der tierishen Veredlung [Handbook of animal improving]. Osnabruek, Germany: Verlag H Kamlage, 1994:145-50(in German).
25. Saunderson CL, Mackinlay J. Changes in body-weight, composition and hepatic enzyme activities in response to dietary methionine, betaine and choline levels in growing chicks. Br J Nutr 1990;63:339-49.
26. Fernandez-Figares I, Wray-Cahen D, Steele NC, et al. Effect of dietary betaine on nutrient utilization and partitioning in the young growing feed-restricted pig. J Anim Sci 2002;80:421-8.
27. Siljander-Rasi H, Peuranen S, Tiihonen K, et al. Effect of equimolar dietary betaine and choline addition on performance, carcass quality and physiological parameters of pigs. J Anim Sci 2003;76:55-62.
28. Park EI, Garrow TA. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem 1999;274:7816-24.
29. Bianchi G, Azzone GF. Oxidation of choline in rat liver mitochondria. J Biol Chem 1964;239:3945-55.
30. Weinhold PA, Sanders R. The oxidation of choline by liver slices and mitochondria during liver development in the rat. Life Sci 1973;13:621-9.
31. Mann PJG, Woodward HE, Qastel JH. Hepatic oxidation of choline and arsenocholine. Biochem J 1938;32:1024-32.
32. Davies SE, Woolf DA, Chalmers RA, Rafter JEM, Iles RA. Proton nmr studies of betaine excretion in the human neonate: consequences for choline and methyl group supply. J Nutr Biochem 1992;3:523-30.
33. Tsuge H, Nakano Y, Onishi H, Futamura Y, Ohashi K. A novel purification and some properties of rat liver mitochondrial choline dehydrogenase. Biochim Biophys Acta 1980;614:274-84.
34. Wilken DR, McMacken ML, Rodriquez A. Choline and betaine aldehyde oxidation by rat liver mitochondria. Biochim Biophys Acta 1970;216:305-17.
35. Kaiser W, Bygrave FL. Incorporation of choline into the outer and inner membranes of isolated rat liver mitochondria. Eur J Biochem 1968;4:582-5.
36. Streumer-Svobodova Z, Drahota Z. The development of oxidative enzymes in rat liver mitochondria. Physiol Bohemoslov 1977;26:525-34.
37. Dragolovich J. Dealing with salt stress in animal cells: the role and regulation of glycine betaine concentrations. J Exp Zool 1994;168:139-44.
38. Zeisel SH, Growdon JH, Wurtman RJ, Magil SG, Logue M. Normal plasma choline responses to ingested lecithin. Neurology 1980;30:1226-9.
39. de Zwart FJ, Slow S, Payne RJ, et al. Glycine betaine and glycine betaine analogues in common foods. Food Chem 2003;83:197-204.
40. Mar MH, Zeisel SH. Betaine in wine: answer to the French paradox? Med Hypotheses 1999;53:383-5.
41. Vos E. Whole grains and coronary heart disease. Am J Clin Nutr 2000;71:1009(letter).
42. Liu S, Manson J, Hu F, Willett W. Reply to E Vos. Am J Clin Nutr 2000;71:1009(letter).
43. Petronini PG, De Angelis E, Borghetti AF, Wheeler KP. Osmotically inducible uptake of betaine via amino acid transport system A in SV-3T3 cells. Biochem J 1994;300:45-50.
44. Uchida S, Yamauchi A, Preston AS, Kwon HM, Handler JS. Medium tonicity regulates expression of the Na(+)- and Cl(-)-dependent betaine transporter in Madin-Darby canine kidney cells by increasing transcription of the transporter gene. J Clin Invest 1993;91:1604-7.
45. Yamauchi A, Uchida S, Kwon HM, et al. Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity. J Biol Chem 1992;267:649-52.
46. Wright SH, Wunz TM, Silva AL. Betaine transport in the gill of a marine mussel, Mytilus californianus. Am J Physiol 1992;263:R226-32.
47. Wunz TM, Wright SH. Betaine transport in rabbit renal brush-border membrane vesicles. Am J Physiol 1993;264:F948-55.
48. Kappes RM, Kempf B, Bremer E. Three transport systems for the osmoprotectant glycine betaine operate in Bacillus subtilis: characterization of OpuD. J Bacteriol 1996;178:5071-9.
49. Bagnasco S, Balaban R, Fales HM, Yang YM, Burg M. Predominant osmotically active organic solutes in rat and rabbit renal medullas. J Biol Chem 1986;261:5872-7.
50. Kettunen H, Peuranen S, Tiihonen K, Saarinen M. Intestinal uptake of betaine in vitro and the distribution of methyl groups from betaine, choline, and methionine in the body of broiler chicks. Comp Biochem Physiol A Mol Integr Physiol 2001;128:269-78.
51. Peters-Regehr T, Bode JG, Kubitz R, Haussinger D. Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (Ito cells). Hepatology 1999;29:173-80.
52. Weik C, Warskulat U, Bode J, Peters-Regehr T, Haussinger D. Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 1998;27:569-75.
53. Wettstein M, Weik C, Holneicher C, Haussinger D. Betaine as an osmolyte in rat liver: metabolism and cell-to-cell interactions. Hepatology 1998;27:787-93.
54. Kim SK, Choi KH, Kim YC. Effect of acute betaine administration on hepatic metabolism of S-amino acids in rats and mice. Biochem Pharmacol 2003;65:1565-74.
55. Frontiera MS, Stabler SP, Kolhouse JF, Allen RH. Regulation of methionine metabolism: effects of nitrous oxide and excess dietary methionine. J Nutr Biochem 1994;5:28-38.
56. Schwahn BC, Hafner D, Hohlfeld T, Balkenhol N, Laryea MD, Wendel U. Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br J Clin Pharmacol 2003;55:6-13.
57. Roti MW, Hatch HL, Sutherland JW, et al. Homocysteine, lipid and glucose responses to betaine supplementation during running in the heat. Med Sci Sports Exerc 2003;35:S271(abstr).
58. Lever M, Sizeland PC, Bason LM, Hayman CM, Chambers ST. Glycine betaine and proline betaine in human blood and urine. Biochim Biophys Acta 1994;1200:259-64.
59. Allen RH, Stabler SP, Lindenbaum J. Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 1993;42:1448-60.
60. Lever M, Sizeland PC, Bason LM, Hayman CM, Robson RA, Chambers ST. Abnormal glycine betaine content of the blood and urine of diabetic and renal patients. Clin Chim Acta 1994;230:69-79.
61. Davies SE, Chalmers RA, Randall EW, Iles RA. Betaine metabolism in human neonates and developing rats. Clin Chim Acta 1988;178:241-9.
62. Dellow WJ, Chambers ST, Barrell GK, Lever M, Robson RA. Glycine betaine excretion is not directly linked to plasma glucose concentrations in hyperglycaemia. Diabetes Res Clin Pract 2001;52:165-9.
63. Dellow WJ, Chambers ST, Lever M, Lunt H, Robson RA. Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia. Diabetes Res Clin Pract 1999;43:91-9.
64. Dellow WJ. Betaine metabolism in health and disease. Biochem Soc Trans 2000;28:A155(abstr).
65. Hayes KC, Pronczuk A, Cook MW, Robbins MC. Betaine in sub-acute and sub-chronic rat studies. Food Chem Toxicol 2003;41:1685-700.
66. du Vigneaud V, Chandler JP, Moyer AW, Keppel DM. The effect of choline on the ability of homocysteine to replace methionine in the diet. J Biol Chem 1939;131:57-76.
67. du Vigneaud V, Dyer HM, Keis MW. A relationship between the nature of the vitamin B complex supplement and the ability of homocysteine to replace methionine in the diet. J Biol Chem 1939;130:325-40.
68. du Vigneaud V, Rachele JR. The concept of transmethylation in mammalian metabolism and its establishment by isotopic labelling through "in vivo" experimentation. In: Shapiro SK, Schlenk F, eds. Transmethylation and methionine biosynthesis. Chicago: University of Chicago Press, 1965.
69. du Vigneaud V, Simmonds S, Chandler JP, Cohn M. A further investigation of the role of betaine in transmethylation reactions in vivo. J Biol Chem 1946;165:639-48.
70. Nocianitri KA, Sakakibara S, Kanno T, Kikuchi H, Kurasaki M, Aoyama Y. Influence of dietary methionine level on the liver metallothionein mRNA level in rats. Biosci Biotechnol Biochem 2002;66:2465-70.
71. Dubnoff JW. Utilization of choline and betaine methyl in the Guinea Pig. Arch Biochem 1949;22:474-5.
72. Dubnoff JW. The role of choline oxidase in labilizing choline methyl. Arch Biochem 1949;24:251-62.
73. Muntz JA. The inability of choline to transfer a methyl group directly to homocysteine for methionine formation. J Biol Chem 1950;182:489-99.
74. Cantoni GL. The nature of the active methyl donor formed enzymatically from L-methionine and adenosinetriphosphate. J Am Chem Soc 1952;74:2942-3.
75. Cantoni GL. S-Adenosylmethionine; a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem 1953;204:403-16.
76. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975;24:721-35.
77. Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol, and the liver: a review. Alcohol 1996;13:395-8.
78. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem 1984;259:9508-13.
79. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 1986;261:1582-7.
80. Barak AJ, Beckenhauer HC, Tuma DJ. Use of S-adenosylmethionine as an index of methionine recycling in rat liver slices. Anal Biochem 1982;127:372-5.
81. Barak AJ, Tuma DJ. Betaine, metabolic by-product or vital methylating agent? Life Sci 1983;32:771-4.
82. Millian NS, Garrow TA. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme. Arch Biochem Biophys 1998;356:93-8.
83. Breksa AP III, Garrow TA. Random mutagenesis of the zinc-binding motif of betaine-homocysteine methyltransferase reveals that Gly 214 is essential. Arch Biochem Biophys 2002;399:73-80.
84. Evans JC, Huddler DP, Jiracek J, et al. Betaine-homocysteine methyltransferase: zinc in a distorted barrel. Structure (Camb) 2002;10:1159-71.
85. Ericson LE, Williams JN, Elvehjem CA. Studies on partially purified betaine-homocysteine transmethylase of liver. J Biol Chem 1955;212:537-44.
86. Finkelstein JD. Methionine metabolism. J Nutr Biochem 1990;1:228-37.
87. Finkelstein JD. Methionine metabolism in liver diseases. Am J Clin Nutr 2003;77:1094-5.
88. Sunden SL, Renduchintala MS, Park EI, Miklasz SD, Garrow TA. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 1997;345:171-4.
89. Rao PV, Garrow TA, John F, Garland D, Millian NS, Zigler JS Jr. Betaine-homocysteine methyltransferase is a developmentally regulated enzyme crystallin in rhesus monkey lens. J Biol Chem 1998;273:30669-74.
90. Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. Regulation of hepatic betaine-homocysteine methyltransferase by dietary betaine. J Nutr 1983;113:519-21.
91. Delgado-Reyes CV, Wallig MA, Garrow TA. Immunohistochemical detection of betaine-homocysteine S-methyltransferase in human, pig, and rat liver and kidney. Arch Biochem Biophys 2001;393:184-6.
92. 13C]methionine. Am J Clin Nutr 1991;54:386-94.
93. Wise CK, Cooney CA, Ali SF, Poirier LA. Measuring 5-adenosylmethionine in whole blood, red blood cells and cultured cells using a fast preparation method and high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997;696:145-52.
94. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr 2002;132:2333S-5S.
95. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998;157(suppl):S40-4.
96. Haussinger D. The role of cellular hydration in the regulation of cell function. Biochem J 1996;313:697-710.
97. Burg MB. Molecular basis for osmoregulation of organic osmolytes in renal medullary cells. J Exp Zool 1994;268:171-5.
98. Petronini PG, De Angelis EM, Borghetti P, Borghetti AF, Wheeler KP. Modulation by betaine of cellular responses to osmotic stress. Biochem J 1992;282:69-73.
99. Petronini PG, De Angelis EM, Borghetti AF, Wheeler KP. Effect of betaine on HSP70 expression and cell survival during adaptation to osmotic stress. Biochem J 1993;293:553-8.
100. de Angelis E, Petronini PG, Borghetti P, Borghetti AF, Wheeler KP. Induction of betaine-gamma-aminobutyric acid transport activity in porcine chondrocytes exposed to hypertonicity. J Physiol 1999;518:187-94.
101. Chambers ST. Betaines: their significance for bacteria and the renal tract. Clin Sci (Lond) 1995;88:25-7.
102. Hanson AD, Rathinasabapathi B, Rivoal J, Burnet M, Dillon MO, Gage DA. Osmoprotective compounds in the Plumbaginaceae: a natural experiment in metabolic engineering of stress tolerance. Proc Natl Acad Sci U S A 1994;91:306-10.
103. Weretilnyk EA, Hanson AD. Molecular cloning of a plant betaine-aldehyde dehydrogenase, an enzyme implicated in adaptation to salinity and drought. Proc Natl Acad Sci U S A 1990;87:2745-9.
104. Soderlund T, Zhu K, Jutila A, Kinnunen PKJ. Effects of betaine on the structural dymanics of Thermomyces (Humicola) lanuginosa lipase. Colloids Surf B Biointerfaces 2002;26:75-83.
105. Hundahl C, Fago A, Malte H, Weber RE. Allosteric effect of water in fish and human hemoglobins. J Biol Chem 2003;278:42769-73.
106. Moeckel G, Dasser HG, Chen TJ, Schmolke M, Guder WG. Bicarbonate- dependent betaine synthesis in rat kidney. Contrib Nephrol 1994;110:46-53.
107. Moeckel GW, Lai LW, Guder WG, Kwon HM, Lien YH. Kinetics and osmoregulation of Na(+)-and Cl(-)-dependent betaine transporter in rat renal medulla. Am J Physiol 1997;272:F100-6.
108. Moeckel GW, Lien YH. Distribution of de novo synthesized betaine in rat kidney: role of renal synthesis on medullary betaine accumulation. Am J Physiol 1997;272:F94-9.
109. Moeckel GW, Lien YH. Bicarbonate dependency of betaine synthesis in cultured LLC-PK1 cells. Am J Physiol 1994;266:F512-5.
110. Moeckel GW, Zhang L, Fogo AB, Hao CM, Pozzi A, Breyer MD. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. J Biol Chem 2003;278:19352-7.
111. Pummer S, Dantzler WH, Lien YH, Moeckel GW, Volker K, Silbernagl S. Reabsorption of betaine in Henle's loops of rat kidney in vivo. Am J Physiol 2000;278:F434-9.
112. Sung CP, Johnstone RM. Evidence for the existence of separate transport mechanisms for choline and betaine in rat kidney. Biochim Biophys Acta 1969;173:548-53.
113. Burg M. Molecular basis for accumulation of compatible osmolytes in mammalian cells. In: Somero GN, Osmond CB, Bolis CL, eds. Water and life. Berlin: Springer, 1992:33-51.
114. Horio M, Ito A, Matsuoka Y, et al. Apoptosis induced by hypertonicity in Madin Darley canine kidney cells: protective effect of betaine. Nephrol Dial Transplant 2001;16:483-90.
115. Yancey PH, Burg MB. Counteracting effects of urea and betaine in mammalian cells in culture. Am J Physiol 1990;258:R198-204.
116. Zhang F, Warskulat U, Haussinger D. Modulation of tumor necrosis factor-alpha release by anisoosmolarity and betaine in rat liver macrophages (Kupffer cells). FEBS Lett 1996;391:293-6.
117. Warskulat U, Zhang F, Haussinger D. Modulation of phagocytosis by anisoosmolarity and betaine in rat liver macrophages (Kupffer cells) and RAW 264.7 mouse macrophages. FEBS Lett 1996;391:287-92.
118. Zhang F, Warskulat U, Wettstein M, Haussinger D. Identification of betaine as an osmolyte in rat liver macrophages (Kupffer cells). Gastroenterology 1996;110:1543-52.
119. Kettunen H, Peuranen S, Tiihonen K. Betaine aids in the osmoregulation of duodenal epithelium of broiler chicks, and affects the movement of water across the small intestinal epithelium in vitro. Comp Biochem Physiol A Mol Integr Physiol 2001;129:595-603.
120. Moeckel GW, Shadman R, Fogel JM, Sadrzadeh SM. Organic osmolytes betaine, sorbitol and inositol are potent inhibitors of erythrocyte membrane ATPases. Life Sci 2002;71:2413-24.
121. Ortiz-Costa S, Sorenson MM, Sola-Penna M. Counteracting effects of urea and methylamines in function and structure of skeletal muscle myosin. Arch Biochem Biophys 2002;408:272-8.
122. Hammer MA, Baltz JM. Betaine is a highly effective organic osmolyte but does not appear to be transported by established organic osmolyte transporters in mouse embryos. Mol Reprod Dev 2002;62:195-202.
123. Alfieri RR, Cavazzoni A, Petronini PG, et al. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J Physiol 2002;540:499-508.
124. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
125. Patrick L. Nonalcoholic fatty liver disease: relationshop to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002;7:276-91.
126. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37:1286-92.
127. Cravo ML, Camilo ME. Hyperhomocysteinemia in chronic alcoholism: relations to folic acid and vitamins B(6) and B(12) status. Nutrition 2000;16:296-302.
128. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002;60: 289-93.
129. Best CH, Huntsman ME. The effects of the components of lecithine upon digestion of fat in the liver. J Physiol 1932;75:405-12.
130. Best CH. The role of the liver in the metabolism of carbohydrate and fat. Lancet 1934;226:1274-7.
131. Best CH, Ferguson GC, Hershey JM. Choline and liver fat in diabetic dogs. J Physiol 1933;79:94-102.
132. Best CH, Channon HJ. The action of choline and other substances in the prevention and cure of fatty livers. Biochem J 1935;29:2651-8.
133. Webster GT. Cirrhosis of the liver among rats receiving diets poor in protein and rich in fat. J Clin Invest 1942;21:385-92.
134. Best CH, Ridout JH, Lucas CC. Alleviation of dietary cirrhosis with betaine and other lipotropic agents. Can J Physiol Pharmacol 1969;47:73-9.
135. Sugiyama K, Akai H, Muramatsu K. Effects of methionine and related compounds on plasma cholesterol level in rats fed a high cholesterol diet. J Nutr Sci Vitaminol (Tokyo) 1986;32:537-49.
136. Turpin P. A double blind study of the effectiveness of Beaufor betaine citrate ampules in the treatment of type IV hyperlipidemias. Sem Hop 1985;61:2420-34.
137. Odle J. Betaine and carnitine. Feed Manage 1996;47:25-7.
138. Yao ZM, Vance DE. Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J Biol Chem 1989;264:11373-80.
139. Zhu X, Song J, Mar MH, Edwards LJ, Zeisel SH. Phosphatidylethano-lamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem J 2003;370:987-93.
140. Ghyczy M, Boros M. Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: a hypothesis. Br J Nutr 2001;85:409-14.
141. Rabinowitch IM. Effects of betaine upon the cholesterol and bilirubin contents of blood plasma in diabetes mellitus. Can Med Assoc J 1936;34:637-41.
142. White P, Marble A, Bogan IK, Smith RM. Enlargement of the liver in diabetic children. Arch Intern Med 1938;62:751-64.
143. Lowe RC. Alimentary lipemia in young diabetics with evidence of liver damage or dysfunction. Clin Med 1939;24:943-50.
144. Neuschwander-Tetri BA. Betaine: an old therapy for a new scourge. Am J Gastroenterol 2001;96:2534-6.
145. Youssef W, McCullough AJ. Diabetes mellitus, obesity, and hepatic steatosis. Semin Gastrointest Dis 2002;13:17-30.
146. Angulo P. Current best treatment for non-alcoholic fatty liver disease. Expert Opin Pharmacother 2003;4:611-23.
147. Angulo P, Lindor KD. Treatment of non-alcoholic steatohepatitis. Baillieres Best Pract Res Clin Gastroenterol 2002;16:797-810.
148. Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001;21:81-8.
149. Tokar JL, Berg CL. Therapeutic options in nonalcoholic fatty liver disease. Curr Treat Options Gastroenterol 2002;5:425-36.
150. Abdelmalek MF, Angulo P, Jorgensen RA, Sylvestre PB, Lindor KD. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001;96:2711-7.
151. Miglio F, Rovati LC, Santoro A, Setnikar I. Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study. Arzneimittelforschung 2000;50:722-7.
152. Kim SK, Kim SY, Kim YC. Effect of betaine administration on metabolism of hepatic glutathione in rats. Arch Pharm Res 1998;21:790-2.
153. Kim SK, Kim YC. Effects of singly administered betaine on hepatotoxicity of chloroform in mice. Food Chem Toxicol 1998;36:655-61.
154. Kim SK, Kim YC. Attenuation of bacterial lipopolysaccharide-induced hepatotoxicity by betaine or taurine in rats. Food Chem Toxicol 2002;40:545-9.
155. Barak AJ, Kemmy RJ. Methotrexate effects on hepatic betaine levels in choline-supplemented and choline-deficient rats. Drug Nutr Interact 1982;1:275-8.
156. Barak AJ, Kemmy RJ, Tuma DJ. The effect of methotrexate on homocysteine methylating agents in rat liver. Drug Nutr Interact 1982;1:303-6.
157. Junnila M, Barak AJ, Beckenhauer HC, Rahko T. Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats. Vet Hum Toxicol 1998;40:263-6.
158. Junnila M, Rahko T, Sukura A, Lindberg LA. Reduction of carbon tetrachloride-induced hepatotoxic effects by oral administration of betaine in male Han-Wistar rats: a morphometric histological study. Vet Pathol 2000;37:231-8.
159. Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury. J Nutr Sci Vitaminol (Tokyo) 1998;44:249-55.
160. Graf D, Kurz AK, Reinehr R, Fischer R, Kircheis G, Haussinger D. Prevention of bile acid-induced apoptosis by betaine in rat liver. Hepatology 2002;36:829-39.
161. McCarty MF. Co-administration of equimolar doses of betaine may alleviate the hepatotoxic risk associated with niacin therapy. Med Hypotheses 2000;55:189-94.
162. Barak AJ, Beckenhauer HC, Tuma DJ. Methionine synthase. A possible prime site of the ethanolic lesion in liver. Alcohol 2002;26:65-7.
163. Barak AJ, Beckenhauer HC, Tuma DJ. Betaine effects on hepatic methionine metabolism elicited by short-term ethanol feeding. Alcohol 1996;13:483-6.
164. Finkelstein JD, Cello JP, Kyle WE. Ethanol-induced changes in methionine metabolism in rat liver. Biochem Biophys Res Commun 1974;61:525-31.
165. Barak AJ, Beckenhauer HC, Junnila M, Tuma DJ. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin Exp Res 1993;17:552-5.
166. Barak AJ, Beckenhauer HC, Tuma DJ. S-adenosylmethionine generation and prevention of alcoholic fatty liver by betaine. Alcohol 1994;11:501-3.
167. Barak AJ, Beckenhauer HC, Badakhsh S, Tuma DJ. The effect of betaine in reversing alcoholic steatosis. Alcohol Clin Exp Res 1997;21:1100-2.
168. Ji C, Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003;124:1488-99.
169. Barak AJ, Beckenhauer HC, Kharbanda KK, Tuma DJ. Chronic ethanol consumption increases homocysteine accumulation in hepatocytes. Alcohol 2001;25:77-81.
170. Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ. Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J Nutr 2003;133:2845-8.
171. Barak AJ, Beckenhauer HC, Hidiroglou N, Camilo ME, Selhub J, Tuma DJ. The relationship of ethanol feeding to the methyl folate trap. Alcohol 1993;10:495-7.
172. Kanbak G, Akyuz F, Inal M. Preventive effect of betaine on ethanol-induced membrane lipid composition and membrane ATPases. Arch Toxicol 2001;75:59-61.
173. Kanbak G, Inal M, Baycu C. Ethanol-induced hepatotoxicity and prolective effect of betaine. Cell Biochem Funct 2001;19:281-5.
174. Noga AA, Zhao Y, Vance DE. An unexpected requirement for phosphatidylethanolamine N-methyltransferase in the secretion of very low density lipoproteins. J Biol Chem 2002;277:42358-65.
175. Lu SC, Huang ZZ, Yang H, Mato JM, Avila MA, Tsukamoto H. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol 2000;279:G178-85.
176. Bosy-Westphal A, Ruschmeyer M, Czech N, et al. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am J Clin Nutr 2003;77:1269-77.
177. Look MP, Riezler R, Reichel C, et al. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase? Scand J Gastroenterol 2000;35:866-72.
178. Forestier M, Banninger R, Reichen J, Solioz M. Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. Biochim Biophys Acta 2003;1638:29-34.
179. Borsook H, Borsook ME. The biochemical basis of betaine-glycocyamine therapy. Ann West Med Surg 1951;5:825-9.
180. Borsook ME, Borsook H. Treatment of cardiac decompensation with betaine and glycocyamine. Ann West Med Surg 1951;5:830-55.
181. Van Zandt V, Borsook H. New biochemical approach to the treatment of congestive heart failure. Ann West Med Surg 1951;5:856-62.
182. Graybiel A, Patterson CA. Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report. Ann West Med Surg 1951;5:863-75.
183. Morrison LM. Arteriosclerosis - recent advances in the dietary and medicinal treatment. JAMA 1951;145:1232-6.
184. Morrison LM. Results of betaine treatment of atherosclerosis. Am J Dig Dis 1952;19:381-4.
185. Morrison LM. Use of betaine-lipotropic combinations in clinical practice. Geriatrics 1953;8:649-55.
186. Panteleimonova TN, Zapadniuk VI. Effect of trimethylglycine on lipid metabolism in experimental atherosclerosis in rabbits. Farmakol Toksikol 1983;46:83-5(in Russian).
187. Zapadniuk VI, Chekman IS, Panteleimonova TN, Tumanov VA. Corrective effect of trimethylglycine on the nicotinamide coenzyme and adenine nucleotide content of the tissues in experimental atherosclerosis. Farmakol Toksikol 1986;49:71-3(in Russian).
188. Zapadniuk VI, Panteleimonova TN. Cholagogic effect of trimethylglycine in normal animals of different ages and in experimental atherosclerosis. Biull Eksp Biol Med 1987;104:30-2(in Russian).
189. Schwab U, Torronen A, Toppinen L, et al. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 2002;76:961-7.
190. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46.
191. Finkelstein JD. Homocysteine: a history in progress. Nutr Rev 2000;58:193-204.
192. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
193. Loscalzo J. Homocysteine and dementias. N Engl J Med 2002;346:466-8.
194. Kittner SJ, Giles WH, Macko RF, et al. Homocyst(e)ine and risk of cerebral infarction in a biracial population: the stroke prevention in young women study. Stroke 1999;30:1554-60.
195. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
196. Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 1976;57:1079-82.
197. Boers GH. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease. Neth J Med 1994;45:34-41.
198. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 2003;133:1291-5.
199. Schwahn BC, Chen Z, Laryea MD, et al. Homocysteine-betaine interactions in a murine model of 5,10-methylenetetrahydrofolate reductase deficiency. FASEB J 2003;17:512-4.
200. Holm PI, Bleie O, Ueland PM, et al. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arterioscler Thromb Vasc Biol 2004;24:301-7.
201. Olthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 2003;133:4135-8.
202. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002;132:2361S-6S.
203. Kang SS. Treatment of hyperhomocyst(e)inemia: physiological basis. J Nutr 1996;126:1273S-5S.
204. Obregon DF, Murthy SN, McNamara DB, Fonseca VA. Novel approaches to the treatment of hyperhomocysteinaemia. Expert Opin Ther Patents 2003;13:1023-35.
205. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill Book Co, 1989:693-734.
206. Ogierde Baulny H, Gerard M, Saudubray JM, Zittoun J. Remethylation defects: guidelines for clinical diagnosis and treatment. Eur J Pediatr 1998;157(suppl):S77-83.
207. Mudd SH, Levy HL. Disorders of transulfuration. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw-Hill, 1983:522-59.
208. Smolin LA, Benevenga NJ, Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr 1981;99:467-72.
209. Wilcken DE, Wilcken B, Dudman NP, Tyrrell PA. Homocystinuria - the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 1983;309:448-53.
210. Dudman NP, Tyrrell PA, Wilcken DE. Homocysteinemia: depressed plasma serine levels. Metabolism 1987;36:198-201.
211. Wiley VC, Dudman NP, Wilcken DE. Free and protein-bound homocysteine and cysteine in cystathionine beta-synthase deficiency: interrelations during short- and long-term changes in plasma concentrations. Metabolism 1989;38:734-9.
212. Cochran FB, Sweetman L, Schmidt K, Barsh G, Kraus J, Packman S. Pyridoxine-unresponsive homocystinuria with an unusual clinical course. Am J Med Genet 1990;35:519-22.
213. Dudman NP, Guo XW, Gordon RB, Dawson PA, Wilcken DE. Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease. J Nutr 1996;126:1295S-300S.
214. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997;20:295-300.
215. Steen MT, Kruger WD, Singh RH, Elsas LJ. Betaine increases methionine/homocysteine ratios and decreases total plasma homocysteine (tHcy) in cystathionine beta-synthase deficiency. J Inherit Metab Dis 2000;23:61(abstr).
216. Matthews A, Johnson TN, Rostami-Hodjegan A, et al. An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria. Br J Clin Pharmacol 2002;54-140-6.
217. Gahl WA, Bernardini I, Chen S, Kurtz D, Horvath K. The effect of oral betaine on vertebral body bone density in pyridoxine-non-responsive homocystinuria. J Inherit Metab Dis 1988;11:291-8.
218. Brens CM, Serra JD, Tomas MLC, Gomez AMG, Monegal MR, Busca AV. Homocystinuria: efficacy of pyridoxine, folic acid and betaine therapy. An Esp Pediatr 1993;1:37-41(in Spanish).
219. Ilan Y, Eid A, Rivkind AI, Weiss D, Dubin Z, Yatziv S. Gastrointestinal involvement in homocystinuria. J Gastroenterol Hepatol 1993;8:60-2.
220. Dudman NP, Wilcken DE, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993;13:1253-60.
221. Orendac M, Zeman J, Stabler SP, et al. Homocystinuria due to cystathionine beta-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis 2003;26:761-73.
222. Surtees R, Bowron A, Leonard J. Cerebrospinal fluid and plasma total homocysteine and related metabolites in children with cystathionine beta-synthase deficiency: the effect of treatment. Pediatr Res 1997;42:577-82.
223. Wendel U, Bremer HJ. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 1984;142:147-50.
224. Hyland K, Smith I, Bottiglieri T, et al. Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 1988;38:459-62.
225. Holme E, Kjellman B, Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 1989;64:1061-4.
226. Haworth JC, Dilling LA, Surtees RA, et al. Symptomatic and asymptomatic methylenetetrahydrofolate reductase deficiency in two adult brothers. Am J Med Genet 1993;45:572-6.
227. Kishi T, Kawamura I, Harada Y, et al. Effect of betaine on S-adenosylmethionine levels in the cerebrospinal fluid in a patient with methylenetetrahydrofolate reductase deficiency and peripheral neuropathy. J Inherit Metab Dis 1994;17:560-5.
228. Al-Essa MA, Al Amir A, Rashed M, et al. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency. Brain Dev 1999;21:345-9.
229. Barshop BA, Steiner RD. In vivo studies of methionine metabolism in homocystinuric patients. J Inherit Metab Dis 2000;23:61(abstr).
230. Bonig H, Daublin G, Schwahn B, Wendel U. Psychotic symptoms in severe MTHFR deficiency and their successful treatment with betaine. Eur J Pediatr 2003;162:200-1.
231. Bartholomew DW, Batshaw ML, Allen RH, et al. Therapeutic approaches to cobalamin-C methylmalonic acidemia and homocystinuria. J Pediatr 1988;112:32-9.
232. Carmel R, Watkins D, Goodman SI, Rosenblatt DS. Hereditary defect of cobalamin metabolism (cblG mutation) presenting as a neurologic disorder in adulthood. N Engl J Med 1988;318:1738-41.
233. Berlow S, Bachman RP, Berry GT, et al. Betaine therapy in homocystinemia. Brain Disfunct 1989;2:10-24.
234. Ribes A, Briones P, Vilaseca MA, et al. Methylmalonic aciduria with homocystinuria: biochemical studies, treatment, and clinical course of a Cbl-C patient. Eur J Pediatr 1990;149:412-5.
235. Sprince H, Parker CM, Josephs JA Jr. Homocysteine-induced convulsions in the rat: protection by homoserine, serine, betaine, glycine and glucose. Agents Actions 1969;1:9-13.
236. Freed WJ, Gillin JC, Wyatt RJ. Anticonvulsant properties of betaine. Epilepsia 1979;20:209-13.
237. Ghoz EH, Freed WJ. Effects of betaine on seizures in the rat. Pharmacol Biochem Behav 1985;22:635-40.
238. Freed WJ. Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine. Pharmacol Biochem Behav 1985;22:641-3.
239. Freed WJ. N,N-dimethylglycine, betaine, and seizures. Arch Neurol 1984;41:1129-30.
240. van der Westhuyzen J, Metz J. Betaine delays the onset of neurological impairment in nitrous oxide-induced vitamin B-12 deficiency in fruit bats. J Nutr 1984;114:1106-11.
241. Van den Veyver IB, Zoghbi HY. Genetic basis of Rett syndrome. Ment Retard Dev Disabil Res Rev 2002;8:82-6.
242. Percy AK. Clinical trials and treatment prospects. Ment Retard Dev Disabil Res Rev 2002;8:106-11.
243. Knopman D, Patterson M. An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients. Alzheimer Dis Assoc Disord 2001;15:162-5.
244. Franken DG, Boers GH, Blom HJ, Trijbels FJ, Kloppenborg PW. Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 1994;14:465-70.
245. van den Berg M, Boers GH. Homocystinuria: what about mild hyperhomocysteinaemia? Postgrad Med J 1996;72:513-8.
246. Brouwer IA, Verhoef P, Urgert R. Betaine supplementation and plasma homocysteine in healthy volunteers. Arch Intern Med 2000;160:2546-7.
247. Wilcken DE, Dudman NP, Tyrrell PA. Homocystinuria due to cystathionine beta-synthase deficiency - the effects of betaine treatment in pyridoxine-responsive patients. Metabolism 1985;34:1115-21.
248. McGregor DO, Dellow WJ, Robson RA, Lever M, George PM, Chambers ST. Betaine supplementation decreases post-methionine hyperhomocysteinemia in chronic renal failure. Kidney Int 2002;61:1040-6.
249. Weisberg IS, Park E, Ballman KV, et al. Investigations of a common genetic variant in betaine-homocysteine methyltransferase (BHMT) in coronary artery disease. Atherosclerosis 2003;167:205-14.
250. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
251. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
252. Schwahn B, Wendel U, Lussier-Cacan S, et al. Effects of betaine in a model of hyperhomocysteinemia due to deficiency of cystathionine-b-synthase. J Inherit Metab Dis 2002;25:35(abstr).
253. Heil SG, Lievers KJ, Boers GH, et al. Betaine-homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab 2000;71:511-9.
254. Morin I, Platt R, Weisberg I, et al. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet 2003;119:172-6.
255. Delgado-Reyes CV, Garrow T. Betaine-homocysteine S-methyltransferase (BHMT) is regulated by tonicity in vivo. FASEB J 2003;17:A738(abstr).
256. Ozturk F, Ucar M, Ozturk IC, Vardi N, Batcioglu K. Carbon tetrachloride-induced nephrotoxicity and protective effect of betaine in Sprague-Dawley rats. Urology 2003;62:353-6.
257. van Guldener C, Janssen MJ, Lambert J, ter Wee PM, Donker AJ, Stehouwer CD. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after longterm therapy. Perit Dial Int 1998;18:282-9.
258. van Guldener C, Janssen MJ, de Meer K, Donker AJ, Stehouwer CD. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Intern Med 1999;245:175-83.
259. Bostom AG, Shemin D, Nadeau MR, et al. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis 1995;113:129-32.
260. Cooney CA. Are somatic cells inherently deficient in methylation metabolism? A proposed mechanism for DNA methylation loss, senescence and aging. Growth Dev Aging 1993;57:261-73.
261. Newberne PM, Rogers AE. Labile methyl groups and the promotion of cancer. Annu Rev Nutr 1986;6:407-32.
262. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.
263. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr 2002;22:255-82.
264. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002;132:2393S-2400S.
265. Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 1998;12:949-57.
266. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003;23:5293-300.
267. Waterland RA. Do maternal methyl supplements in mice affect DNA methylation of offspring? J Nutr 2003;133:238(letter).
268. Borsook ME, Billig HK, Golseth JG. Betaine and glycocamine in the treatment of disability resulting from acute anterior poliomyelitis. Ann West Med Surg 1952;6:423-7.
269. Borsook H, Borsook ME, inventors; California Institute Research Foundation, assignee. Glycocyamine and methylating agent in vivo creatine producing composition. US patent 2,761,807. September 4, 1956.
270. Liversedge LA. Glycocyamine and betaine in motor-neurone disease. Lancet 1956;2:1136-8.
271. Armstrong LE, Roti MW, Hatch HL, et al. Rehydration with fluids containing betaine: running performance and metabolism in a 31 C environment. Med Sci Sports Exerc 2003;35:S311(abstr).